Market Overview:
The global injectable drug packaging market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for injectable drugs, rising prevalence of chronic diseases, and technological advancements in the field of drug packaging. Based on type, the global injectable drug packaging market is segmented into ampules, vials, cartridges, and bottles. Ampules are further classified into glass ampules and plastic ampules while vials are further classified into glass vials and plastic vials. The cartridge segment is expected to grow at a higher CAGR during the forecast period as compared to other segments due to its growing popularity among end users owing to its benefits such as easy handling and less wastage.
Product Definition:
Injectable drug packaging is the process of enclosing a drug in a container to protect it from the environment. This type of packaging is important because it prevents the drug from being contaminated and keeps it sterile.
Ampules:
Ampules are small glass or plastic vials containing a sterile solution for injection. Ampules can be used to contain various types of injectable drugs such as vitamins, antibiotics, hormones and others. The ampule is an important pharmaceutical packaging element that has witnessed significant changes over the past years due to its growing application in drug delivery systems.
Vials:
Vials are glass or plastic bottles that are used to contain a specific dose of medication for injection. They have various sizes and shapes, which help in minimizing the risk of contamination. The vial is specifically designed to deliver precise doses at a fixed time with zero chances of error. It helps in delivering accurate dosage every time and thus it has high importance in injectable packaging market as they provide safety, sterility, and prevent leakage & degradation of drugs during transport & storage.
Application Insights:
Based on application, the global injectable drug packaging market is segmented into hospitals and clinics, home care settings, and other facilities of use. Hospitals and clinics held the largest share in 2017 owing to increasing usage of these products for various medical purposes such as hydration therapy, chemotherapy administration along with ease of handling by healthcare professionals.
The home care setting segment is expected to witness significant growth over the forecast period due to rising geriatric population base across the globe which requires specific medications for treatment. Moreover, growing awareness among patients regarding medication compliance along with convenience offered by this packaging will boost demand in near future. Other facilities of use include pharmacies and veterinary hospitals where these are used for dispensing different types of injections including vitamins & minerals among others. Growing demand from pharmaceutical industries will also fuel product demand in other applications during 2018-2030 period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to high healthcare expenditure, technological advancements, and increasing number of product launches. In addition, presence of major players in this region is also contributing towards growth of the market for global INDPs.
Asia Pacific is anticipated to witness lucrative CAGR over the forecast period due to rising geriatric population base and growing awareness about chronic diseases & associated treatment options in emerging economies such as China & India. Moreover, government initiatives for improving public health system are also driving growth of this regional market during the same period. For instance; Government Of India’s National Health Mission (NHM) aims at reducing target disease burden by 25% between 2010 and 2020 through improved primary healthcare services at community level clinics run by Public Health Foundation Of India (PHFI).
Growth Factors:
- Increasing demand for injectable drugs due to their benefits over traditional oral medications
- Growing prevalence of chronic diseases that require regular injections
- Rising number of drug recalls due to packaging failures, which is driving the demand for better quality packaging solutions
- Rapid technological advancements in the field of injectable drug packaging that are making these products more reliable and user-friendly
- Growing focus on patient safety and convenience across the healthcare industry
Scope Of The Report
Report Attributes
Report Details
Report Title
Injectable Drug Packaging Market Research Report
By Type
Ampules, Vials, Cartridges, Bottles
By Application
Hospitals & Clinics, Home Care Settings, Other Facilities of Use
By Companies
Becton,Dickinson and Company (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (U.S.), Baxter International, Inc. (U.S.), Schott AG (Germany), Gerresheimer (Germany), Ypsomed (Switzerland), B. Braun Melsungen (Germany)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
143
Number of Tables & Figures
101
Customization Available
Yes, the report can be customized as per your need.
Global Injectable Drug Packaging Market Report Segments:
The global Injectable Drug Packaging market is segmented on the basis of:
Types
Ampules, Vials, Cartridges, Bottles
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Clinics, Home Care Settings, Other Facilities of Use
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Becton,Dickinson and Company (U.S.)
- Pfizer Inc. (U.S.)
- Teva Pharmaceuticals Industries Ltd. (Israel)
- Eli Lilly and Company (U.S.)
- Baxter International, Inc. (U.S.)
- Schott AG (Germany)
- Gerresheimer (Germany)
- Ypsomed (Switzerland)
- B. Braun Melsungen (Germany)
Highlights of The Injectable Drug Packaging Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Ampules
- Vials
- Cartridges
- Bottles
- By Application:
- Hospitals & Clinics
- Home Care Settings
- Other Facilities of Use
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Injectable Drug Packaging Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Injectable drug packaging is a type of pharmaceutical packaging that allows drugs to be administered by injection. The package typically includes a sterile container for the drug, an injector, and instructions for use.
Some of the major companies in the injectable drug packaging market are Becton,Dickinson and Company (U.S.), Pfizer Inc. (U.S.), Teva Pharmaceuticals Industries Ltd. (Israel), Eli Lilly and Company (U.S.), Baxter International, Inc. (U.S.), Schott AG (Germany), Gerresheimer (Germany), Ypsomed (Switzerland), B. Braun Melsungen (Germany).
The injectable drug packaging market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Injectable Drug Packaging Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Injectable Drug Packaging Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Injectable Drug Packaging Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Injectable Drug Packaging Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Injectable Drug Packaging Market Size & Forecast, 2018-2028
4.5.1 Injectable Drug Packaging Market Size and Y-o-Y Growth
4.5.2 Injectable Drug Packaging Market Absolute $ Opportunity
Chapter 5 Global Injectable Drug Packaging Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Injectable Drug Packaging Market Size Forecast by Type
5.2.1 Ampules
5.2.2 Vials
5.2.3 Cartridges
5.2.4 Bottles
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Injectable Drug Packaging Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Injectable Drug Packaging Market Size Forecast by Applications
6.2.1 Hospitals & Clinics
6.2.2 Home Care Settings
6.2.3 Other Facilities of Use
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Injectable Drug Packaging Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Injectable Drug Packaging Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Injectable Drug Packaging Analysis and Forecast
9.1 Introduction
9.2 North America Injectable Drug Packaging Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Injectable Drug Packaging Market Size Forecast by Type
9.6.1 Ampules
9.6.2 Vials
9.6.3 Cartridges
9.6.4 Bottles
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Injectable Drug Packaging Market Size Forecast by Applications
9.10.1 Hospitals & Clinics
9.10.2 Home Care Settings
9.10.3 Other Facilities of Use
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Injectable Drug Packaging Analysis and Forecast
10.1 Introduction
10.2 Europe Injectable Drug Packaging Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Injectable Drug Packaging Market Size Forecast by Type
10.6.1 Ampules
10.6.2 Vials
10.6.3 Cartridges
10.6.4 Bottles
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Injectable Drug Packaging Market Size Forecast by Applications
10.10.1 Hospitals & Clinics
10.10.2 Home Care Settings
10.10.3 Other Facilities of Use
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Injectable Drug Packaging Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Injectable Drug Packaging Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Injectable Drug Packaging Market Size Forecast by Type
11.6.1 Ampules
11.6.2 Vials
11.6.3 Cartridges
11.6.4 Bottles
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Injectable Drug Packaging Market Size Forecast by Applications
11.10.1 Hospitals & Clinics
11.10.2 Home Care Settings
11.10.3 Other Facilities of Use
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Injectable Drug Packaging Analysis and Forecast
12.1 Introduction
12.2 Latin America Injectable Drug Packaging Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Injectable Drug Packaging Market Size Forecast by Type
12.6.1 Ampules
12.6.2 Vials
12.6.3 Cartridges
12.6.4 Bottles
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Injectable Drug Packaging Market Size Forecast by Applications
12.10.1 Hospitals & Clinics
12.10.2 Home Care Settings
12.10.3 Other Facilities of Use
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Injectable Drug Packaging Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Injectable Drug Packaging Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Injectable Drug Packaging Market Size Forecast by Type
13.6.1 Ampules
13.6.2 Vials
13.6.3 Cartridges
13.6.4 Bottles
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Injectable Drug Packaging Market Size Forecast by Applications
13.10.1 Hospitals & Clinics
13.10.2 Home Care Settings
13.10.3 Other Facilities of Use
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Injectable Drug Packaging Market: Competitive Dashboard
14.2 Global Injectable Drug Packaging Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Becton,Dickinson and Company (U.S.)
14.3.2 Pfizer Inc. (U.S.)
14.3.3 Teva Pharmaceuticals Industries Ltd. (Israel)
14.3.4 Eli Lilly and Company (U.S.)
14.3.5 Baxter International, Inc. (U.S.)
14.3.6 Schott AG (Germany)
14.3.7 Gerresheimer (Germany)
14.3.8 Ypsomed (Switzerland)
14.3.9 B. Braun Melsungen (Germany)
